Trump administration releases $600 million in Gavi vaccine funding previously paused by HHS

The Trump administration announced Wednesday that it will release $600 million in congressionally appropriated funding for Gavi, the Vaccine Alliance, a Geneva-based immunization program that supports childhood vaccination efforts in lower-income countries. The administration framed the decision as an execution of congressional funding already in place and described it as restoring U.S. support for the immunization initiative. The Hill reported that the release reverses an earlier decision in the prior year by Health and Human Services Secretary Robert F. Kennedy Jr. to halt U.S. funding for Gavi. According to the report, Kennedy’s action was implemented through the administration’s control over how appropriated immunization funds are distributed and disbursed. The announcement comes with children in focus: Gavi’s program role is to support routine vaccines and other immunization activity for children in countries with higher rates of preventable disease risk. The administration’s stated practical effect, as described by The Hill, is to allow those congressionally funded immunization activities to resume after a prior pause. The release also underscores the operational role of the Department of Health and Human Services in administering foreign assistance and global health immunization programs funded by Congress. While Congress appropriates money, the department’s decisions on whether and when to distribute appropriated funds can determine whether grantees and implementing partners receive resources for planned vaccine deliveries and related support. In response to the prior pause, the administration’s Wednesday action shifts the timing of funding flows and could affect program continuity for vaccine schedules supported by Gavi. The Hill did not detail a specific disbursement schedule or whether the money will cover particular vaccine procurement cycles, but the practical consequence described in the report is that the funding will be released for continued global immunization work. The decision also highlights an intra-executive branch policy dispute over how the administration interprets the appropriate use of appropriated funds for global health programs. With the release now announced, the key next steps are the department’s implementation actions: processing the release, communicating with implementing partners, and managing disbursement timelines so that immunization activities can proceed. The administration’s move is likely to draw further attention from lawmakers and stakeholders because it involves both congressional spending authority and HHS execution of that authority. For any additional adjustments, the department would typically need to follow the same legal and administrative processes used to distribute appropriated funds, including documentation required for grant or partner payments tied to the immunization effort.